| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.018 | 0.9 |